Home » BioDiscovery, Exiqon Ink Deal to Sell miRNA Analysis Package

BioDiscovery, Exiqon Ink Deal to Sell miRNA Analysis Package

May 06, 2010
Premium

BioDiscovery and Exiqon announced this week a deal to package BioDiscovery's array image-analysis software with Exiqon's microRNA arrays.

"The partnership … provides a complete well integrated solution for microRNA array studies, going from array experiment with Exiqon's miRcury LNA microRNA arrays to final results with data analysis and visualization from BioDiscovery software," BioDiscovery President Soheil Shams said in a statement.

Financial terms of the arrangement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

May
08
Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

What's Popular?

In Gene Silencing/Gene Editing

  1. Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen

  2. Bioinformatics Pipeline Annotates CRISPR Repeats, Cas Genes; Assembles Data in One Repository

    Premium

  3. Researchers Identify Essential Genes for Pluripotent Stem Cells Through CRISPR-Cas9 Screening

  4. Chemotherapy Resistance Pathway for AML Identified in CRISPRa Screen

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.